Menu

Village Global

The World is a Village

in

FDA OKs Subcutaneous Atezolizumab for Multiple Cancers

Source link : https://www.newshealth.biz/health-news/fda-oks-subcutaneous-atezolizumab-for-multiple-cancers/

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications of the intravenous (IV) formulation. Approved indications include non–small-cell lung cancer (NSCLC), small-cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma. Specific indications are available with the […]

Author : News Health

Publish date : 2024-09-16 07:30:23

Copyright for syndicated content belongs to the linked Source.

Exit mobile version